Different regulatory approaches to excipient requirements: the case of EG/DEG contamination risk in pharmaceuticals
International Journal of Pharmaceutical Excipients · 30.06.2026 · 3 (2)
DOI: 10.66617/001c.164292 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Excipients, online erschienen am 30.06.2026. Verfasst von Miquel Mir.
Abstract (Originalsprache)
Ethylene glycol (EG) and diethylene glycol (DEG) contamination of pharmaceutical excipients has repeatedly resulted in severe poisoning events, particularly in oral paediatric medicines, with fatalities continuing to be reported outside highly regulated regions. These incidents have largely been attributed to economically motivated adulteration of widely used excipients such as glycerol and propylene glycol. In response, regulatory authorities and pharmacopeial bodies have implemented measures to mitigate this risk; however, the scope, stringency, and regulatory philosophy of these measures vary significantly across jurisdictions.
Zitieren
APA
Mir, M. (2026). Different regulatory approaches to excipient requirements: the case of EG/DEG contamination risk in pharmaceuticals. International Journal of Pharmaceutical Excipients, 3(2). https://doi.org/10.66617/001c.164292
Vancouver
Mir M. Different regulatory approaches to excipient requirements: the case of EG/DEG contamination risk in pharmaceuticals. International Journal of Pharmaceutical Excipients. 2026;3(2). doi:10.66617/001c.164292
BibTeX
@article{Mir2026,
author = {Mir, Miquel},
title = {Different regulatory approaches to excipient requirements: the case of EG/DEG contamination risk in pharmaceuticals},
journal = {International Journal of Pharmaceutical Excipients},
year = {2026},
volume = {3},
number = {2},
doi = {10.66617/001c.164292}
}
EUVIMED